speb/financial-data huggingface dataset:
Financial ratios for AVN.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -61155.47445255474
Operating income: -1742845.2554744524
Net income: -1798287.591240876
Capital expenditures: 447443.79562043794
Operating cash flow: -2030480.2919708027
Depreciation & amortization: 61155.47445255474
Net tangible assets: 17576769.34306569
Owner earnings: -2184575.912408759
Return on net tangible assets (%): -12.428768164216754
Buffett classification: The Gruesome
Shares outstanding: 128754916
Book value: 17576769.34306569
Debt to equity: 0.01143230941769773
Current ratio: 0.3242207911683533
Quick ratio: 0.3242207911683533
Interest coverage ratio: -59.75070693926578
Free cash flow (dilution-adjusted): -2482696.3503649635
Retained earnings: -37977867.88321167
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.708111954218104
Rule of 40 score: 0
Financial ratios for AVN.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -15719.70802919708
Operating income: -261761.31386861313
Net income: -225128.46715328464
Capital expenditures: 228843.79562043794
Operating cash flow: -742629.1970802919
Depreciation & amortization: 15719.70802919708
Net tangible assets: 17576769.34306569
Owner earnings: -438252.55474452546
Return on net tangible assets (%): -2.4933623818498987
Buffett classification: The Gruesome
Shares outstanding: 128754916
Book value: 17576769.34306569
Debt to equity: 0.01143230941769773
Current ratio: 0.3242207911683533
Quick ratio: 0.3242207911683533
Interest coverage ratio: -27.36668192918193
Free cash flow (dilution-adjusted): -907964.2335766422
Retained earnings: -37977867.88321167
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4580801894703672
Rule of 40 score: 0
Financial ratios for CSC.AX — annual report dated 2022-12-31
Total revenue: 1011852205.8823528
Gross profit: 152791176.47058824
Operating income: 98338235.29411764
Net income: 100102205.88235293
Capital expenditures: 411582352.9411764
Operating cash flow: 64280882.35294117
Depreciation & amortization: 129538970.58823529
Net tangible assets: 2022953676.4705882
Owner earnings: -181941176.4705882
Return on net tangible assets (%): -8.993837999692499
Capex to operating income (%): 418.53746074472855
Buffett classification: The Gruesome
Shares outstanding: 763791402
Book value: 2338129411.7647057
Debt to equity: 0.22107038809304574
Current ratio: 1.3939936161671547
Quick ratio: 1.049352315118522
Effective tax rate (%): 29.724190975681523
Interest coverage ratio: 6.306110901546586
COGS to revenue (%): 79.07949821200056
SG&A to revenue (%): 4.214751776554207
Free cash flow (dilution-adjusted): -370651470.58823526
Retained earnings: 193023529.41176468
Inventory turnover: 7.729056727060946
Receivables turnover: 7.171507189126935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6896598326433883
FCF margin (%): -36.63098903510525
Rule of 40 score: -36.63098903510525
Financial ratios for CSC.AX — annual report dated 2023-12-31
Total revenue: 1077600757.5757575
Gross profit: 62890151.515151516
Operating income: 13671212.121212121
Net income: -77024242.42424242
Capital expenditures: 467218939.3939394
Operating cash flow: 88497727.27272727
Depreciation & amortization: 180450757.57575756
Net tangible assets: 2015596212.121212
Owner earnings: -363792424.24242425
Return on net tangible assets (%): -18.04887417701432
Capex to operating income (%): 3417.5385126897927
Buffett classification: The Gruesome
Shares outstanding: 763791402
Book value: 2322819696.969697
Debt to equity: 0.3785801739134972
Current ratio: 1.1274535686165532
Quick ratio: 0.780982816914455
Interest coverage ratio: 1.2045120811640635
COGS to revenue (%): 88.75609606919976
SG&A to revenue (%): 3.1723111035809772
Free cash flow (dilution-adjusted): -393118939.3939394
Retained earnings: 127943939.39393939
Inventory turnover: 8.43841110063965
Receivables turnover: 9.65552749833693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3316002385110881
FCF margin (%): -36.48094497245213
Revenue growth (%): 6.497841415097849
Rule of 40 score: -29.98310355735428
Financial ratios for CYAB — annual report dated 2022-12-31
Total revenue: 798000
Gross profit: 524000
Operating income: -5681000
Net income: -6061000
Capital expenditures: 125000
Operating cash flow: -4468000
Depreciation & amortization: 28000
Net tangible assets: -4812000
Owner earnings: -6158000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -4812000
Debt to equity: -0.6396508728179551
Current ratio: 1.000507614213198
Quick ratio: 1.000507614213198
Interest coverage ratio: -42.08148148148148
COGS to revenue (%): 34.335839598997495
R&D to revenue (%): 376.3157894736842
SG&A to revenue (%): 401.25313283208015
Free cash flow (dilution-adjusted): -4826000
Retained earnings: -12394000
Receivables turnover: 9.279069767441861
Capitalized R&D asset: 3003000
ROCI (R&D-adjusted, %): -111.89172749391727
FCF margin (%): -604.7619047619047
Rule of 40 score: -604.7619047619047
Financial ratios for CYAB — annual report dated 2023-12-31
Total revenue: 1922000
Gross profit: 1319000
Operating income: -5941000
Net income: -6550000
Capital expenditures: 18000
Operating cash flow: -4443000
Depreciation & amortization: 39000
Net tangible assets: -4609000
Owner earnings: -6529000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -4609000
Debt to equity: -0.5630288565849425
Current ratio: 0.1838600156698877
Quick ratio: 0.1838600156698877
Interest coverage ratio: -20.772727272727273
COGS to revenue (%): 31.3735691987513
R&D to revenue (%): 186.9406867845994
SG&A to revenue (%): 190.7908428720083
Free cash flow (dilution-adjusted): -4938000
Retained earnings: -18944000
Receivables turnover: 27.457142857142856
Capitalized R&D asset: 5605010
ROCI (R&D-adjusted, %): -173.60249356308935
Rosenberg metric: 0.2647352647352647
FCF margin (%): -256.91987513007285
Revenue growth (%): 140.85213032581453
Rule of 40 score: -116.06774480425833
Financial ratios for CYAB — annual report dated 2024-12-31
Total revenue: 4155000
Gross profit: 3373000
Operating income: -9198000
Net income: -15610000
Capital expenditures: 85000
Operating cash flow: -5196000
Depreciation & amortization: 46000
Net tangible assets: -18640000
Owner earnings: -15649000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -18640000
Debt to equity: -0.729667381974249
Current ratio: 0.06889157686386628
Quick ratio: 0.06889157686386628
Interest coverage ratio: -42.583333333333336
COGS to revenue (%): 18.82069795427196
R&D to revenue (%): 111.985559566787
SG&A to revenue (%): 190.56558363417568
Free cash flow (dilution-adjusted): -6833000
Retained earnings: -34554000
Receivables turnover: 36.769911504424776
Capitalized R&D asset: 8051300
Rosenberg metric: 0.5716671305315892
FCF margin (%): -164.45246690734055
Revenue growth (%): 116.18106139438085
Rule of 40 score: -48.2714055129597
Financial ratios for CYAB — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -18640000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -18640000
Debt to equity: -0.729667381974249
Current ratio: 0.06889157686386628
Quick ratio: 0.06889157686386628
Retained earnings: -34554000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYAB — quarterly report dated 2025-03-31
Total revenue: 1260000
Gross profit: 1064000
Operating income: -4038000
Net income: -3314000
Capital expenditures: 12000
Operating cash flow: -1273000
Depreciation & amortization: 14000
Owner earnings: -3312000
Buffett classification: The Gruesome
Shares outstanding: 15239281
COGS to revenue (%): 15.555555555555555
R&D to revenue (%): 146.90476190476193
SG&A to revenue (%): 258.015873015873
Free cash flow (dilution-adjusted): -2674000
Capitalized R&D asset: 1851000
ROCI (R&D-adjusted, %): -151.4856834143706
FCF margin (%): -212.22222222222223
Rule of 40 score: -212.22222222222223
Financial ratios for CYAB — quarterly report dated 2025-06-30
Total revenue: 1331000
Gross profit: 1118000
Operating income: -3419000
Net income: -2446000
Capital expenditures: 17000
Operating cash flow: -2560000
Depreciation & amortization: 15000
Net tangible assets: -18655000
Owner earnings: -2448000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -18655000
Debt to equity: -0.7013133208255159
Current ratio: 0.03760621000734291
Quick ratio: 0.03760621000734291
COGS to revenue (%): 16.003005259203608
R&D to revenue (%): 138.24192336589033
SG&A to revenue (%): 202.62960180315554
Free cash flow (dilution-adjusted): -3443000
Retained earnings: -40314000
Receivables turnover: 4.719858156028369
Capitalized R&D asset: 3080170
Rosenberg metric: 0.029173419773095625
FCF margin (%): -258.6776859504132
Revenue growth (%): 5.634920634920635
Rule of 40 score: -253.04276531549257
Financial ratios for CYAB — quarterly report dated 2025-09-30
Total revenue: 1487000
Gross profit: 1312000
Operating income: -2158000
Net income: -2741000
Capital expenditures: 18000
Operating cash flow: -2692000
Depreciation & amortization: 13000
Net tangible assets: -20823000
Owner earnings: -2746000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -20823000
Debt to equity: -0.7532055899726264
Current ratio: 0.025051604428598235
Quick ratio: 0.025051604428598235
COGS to revenue (%): 11.768661735036986
R&D to revenue (%): 111.43241425689308
SG&A to revenue (%): 121.92333557498318
Free cash flow (dilution-adjusted): -3159000
Retained earnings: -43055000
Receivables turnover: 5.653992395437262
Capitalized R&D asset: 3500630
Rosenberg metric: 0.10543478260869565
FCF margin (%): -212.4411566913248
Revenue growth (%): 11.720510894064613
Rule of 40 score: -200.7206457972602
Financial ratios for CYAB — annual report dated 2025-12-31
Total revenue: 5707000
Gross profit: 4841000
Operating income: -11970000
Net income: -12819000
Capital expenditures: 54000
Operating cash flow: -8144000
Depreciation & amortization: 58000
Net tangible assets: -24771000
Owner earnings: -12815000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -24771000
Debt to equity: -0.7785313471398005
Current ratio: 0.028929188255613126
Quick ratio: 0.028929188255613126
Interest coverage ratio: -24.279918864097365
COGS to revenue (%): 15.174347292798318
R&D to revenue (%): 120.79901874890486
SG&A to revenue (%): 173.76905554582092
Free cash flow (dilution-adjusted): -11223000
Retained earnings: -47373000
Receivables turnover: 21.21561338289963
Capitalized R&D asset: 11197200
Rosenberg metric: 0.3154953793251666
FCF margin (%): -196.6532328719117
Revenue growth (%): 37.352587244283995
Rule of 40 score: -159.30064562762772
Financial ratios for CYAB — quarterly report dated 2025-12-31
Total revenue: 1629000
Gross profit: 1347000
Operating income: -2355000
Net income: -4318000
Capital expenditures: 7000
Operating cash flow: -1619000
Depreciation & amortization: 16000
Net tangible assets: -24771000
Owner earnings: -4309000
Buffett classification: The Gruesome
Shares outstanding: 15239281
Book value: -24771000
Debt to equity: -0.7785313471398005
Current ratio: 0.028929188255613126
Quick ratio: 0.028929188255613126
COGS to revenue (%): 17.311233885819522
R&D to revenue (%): 94.96623695518723
SG&A to revenue (%): 346.7157765500307
Free cash flow (dilution-adjusted): -1947000
Retained earnings: -47373000
Receivables turnover: 6.055762081784387
Capitalized R&D asset: 3264390
Rosenberg metric: 0.02112251056125528
FCF margin (%): -119.52117863720073
Revenue growth (%): 9.549428379287155
Rule of 40 score: -109.97175025791358
Financial ratios for ICFG.L — annual report dated 2022-06-30
Total revenue: 51.768292682926834
Operating income: -586774.8658536586
Net income: -588650.4024390244
Capital expenditures: 0
Operating cash flow: -473491.35365853657
Net tangible assets: 278119.1219512195
Owner earnings: -588650.4024390244
Return on net tangible assets (%): -211.65405611422514
Buffett classification: The Gruesome
Shares outstanding: 203957116
Book value: 278119.1219512195
Debt to equity: 0
Current ratio: 6.689572130143488
Quick ratio: 6.689572130143488
Interest coverage ratio: -647.1491459314057
COGS to revenue (%): 0
SG&A to revenue (%): 790421.4605418139
Free cash flow (dilution-adjusted): -547447.7926829269
Retained earnings: -588650.4024390244
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -210.9796916288897
FCF margin (%): -1057496.3250883394
Rule of 40 score: -1057496.3250883394
Financial ratios for LATA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -95
Buffett classification: The Gruesome
Shares outstanding: 17250000
Book value: -95
Debt to equity: -504.6842105263158
Current ratio: 0.3992334717342702
Quick ratio: 0.3992334717342702
Retained earnings: -25095
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LATA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -107577
Net income: 43587
Capital expenditures: 0
Operating cash flow: -222116
Net tangible assets: 167783089
Owner earnings: 43587
Return on net tangible assets (%): 0.025978184249546152
Buffett classification: The Gruesome
Shares outstanding: 17250000
Book value: 167783089
Debt to equity: 0
Current ratio: 13.453675747192726
Quick ratio: 13.453675747192726
Free cash flow (dilution-adjusted): -222116
Retained earnings: -4868650
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.06188967637199757
Rule of 40 score: 0
Financial ratios for LMRI — annual report dated 2023-12-31
Total revenue: 935925000
Gross profit: 98967000
Operating income: -12828000
Net income: -122227000
Capital expenditures: 24007000
Operating cash flow: 37514000
Depreciation & amortization: 72066000
Net tangible assets: -667501000
Owner earnings: -74168000
Buffett classification: The Gruesome
Shares outstanding: 96080735
Book value: 198426000
Debt to equity: 6.575388305967968
Current ratio: 1.0350805325388697
Quick ratio: 1.0350805325388697
Interest coverage ratio: -0.09053312066848279
COGS to revenue (%): 89.42575526885167
SG&A to revenue (%): 5.894168870368886
Free cash flow (dilution-adjusted): -41789000
Retained earnings: -489857000
Receivables turnover: 7.185328778165905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8493046930241549
FCF margin (%): -4.464994524133878
Rule of 40 score: -4.464994524133878
Financial ratios for LMRI — quarterly report dated 2024-12-31
Total revenue: 248028000
Gross profit: 21572000
Operating income: -8400000
Net income: -25058000
Capital expenditures: 5582000
Operating cash flow: 25310000
Depreciation & amortization: 13576000
Net tangible assets: -693688000
Owner earnings: -17064000
Buffett classification: The Gruesome
Shares outstanding: 96080735
Book value: 161654000
Debt to equity: 8.099168594652777
Current ratio: 0.9934354485776805
Quick ratio: 0.9934354485776805
Interest coverage ratio: -0.2676267244400548
COGS to revenue (%): 91.30259486832132
SG&A to revenue (%): 8.111987356266228
Free cash flow (dilution-adjusted): 5402000
Retained earnings: -583956000
Receivables turnover: 1.8237621141487375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5611582305879336
FCF margin (%): 2.177979905494541
Rule of 40 score: 2.177979905494541
Financial ratios for LMRI — annual report dated 2024-12-31
Total revenue: 948869000
Gross profit: 96263000
Operating income: -16262000
Net income: -94099000
Capital expenditures: 27412000
Operating cash flow: 40727000
Depreciation & amortization: 57125000
Net tangible assets: -693688000
Owner earnings: -64386000
Buffett classification: The Gruesome
Shares outstanding: 96080735
Book value: 161654000
Debt to equity: 8.099168594652777
Current ratio: 0.9934354485776805
Quick ratio: 0.9934354485776805
Interest coverage ratio: -0.1195497952612349
COGS to revenue (%): 89.85497471199923
SG&A to revenue (%): 7.415249101825435
Free cash flow (dilution-adjusted): -43700000
Retained earnings: -583956000
Receivables turnover: 6.977080545302137
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.086375612597735
FCF margin (%): -4.605482948647284
Revenue growth (%): 1.3830168015599542
Rule of 40 score: -3.2224661470873297
Financial ratios for LMRI — quarterly report dated 2025-03-31
Total revenue: 245001000
Gross profit: 36604000
Operating income: 10061000
Net income: -7687000
Capital expenditures: 720000
Operating cash flow: -13962000
Depreciation & amortization: 12790000
Owner earnings: 4383000
Capex to operating income (%): 7.156346287645363
Buffett classification: The Great
Shares outstanding: 96080735
Interest coverage ratio: 0.3370632181982646
COGS to revenue (%): 85.0596528177436
SG&A to revenue (%): 7.139562695662467
Free cash flow (dilution-adjusted): -21337000
Capitalized R&D asset: 0
FCF margin (%): -8.708944045126346
Revenue growth (%): -1.220426726014805
Rule of 40 score: -9.929370771141151
Financial ratios for LMRI — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -683313000
Buffett classification: The Gruesome
Shares outstanding: 96080735
Book value: 167107000
Debt to equity: 7.863057801288995
Current ratio: 0.9218020800924486
Quick ratio: 0.9218020800924486
Retained earnings: -602370000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLUAV.PA — annual report dated 2021-12-31
Total revenue: 3416517.784090909
Gross profit: 3233829.9545454546
Operating income: 301291.2386363636
Net income: 474787.8977272727
Capital expenditures: 0
Depreciation & amortization: 571675.5681818182
Net tangible assets: -977721.9545454545
Owner earnings: 1046463.4659090909
Return on net tangible assets (%): -107.03078324507855
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 4246560
Book value: 2686070.1363636362
Debt to equity: 1.0044082819674562
Current ratio: 2.033801900062901
Quick ratio: 1.9710408994947965
Effective tax rate (%): 0
Interest coverage ratio: 7.074100330150645
COGS to revenue (%): 5.347193870792784
Retained earnings: 474787.8977272727
Inventory turnover: 2.324494779529446
Receivables turnover: 198.51710832045228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.807738057736681
Rule of 40 score: 0
Financial ratios for MLUAV.PA — annual report dated 2022-12-31
Capital expenditures: 206610.63829787236
Operating cash flow: -215674.4680851064
Buffett classification: The Gruesome
Shares outstanding: 4246560
Free cash flow (dilution-adjusted): -2327947.872340426
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCTVV — annual report dated 2022-12-31
Total revenue: 1368311000
Gross profit: 946850000
Operating income: 297442000
Net income: 256038000
Capital expenditures: 12874000
Operating cash flow: 404574000
Depreciation & amortization: 105641000
Owner earnings: 348805000
Capex to operating income (%): 4.328238782687045
Buffett classification: The Great
Shares outstanding: 257412788
Effective tax rate (%): 14.569138677753235
COGS to revenue (%): 30.801550232366765
R&D to revenue (%): 8.88716088666977
SG&A to revenue (%): 31.263068118285975
Free cash flow (dilution-adjusted): 285350000
Capitalized R&D asset: 121604000
ROCI (R&D-adjusted, %): 311.2655285462101
FCF margin (%): 20.854177157093673
Rule of 40 score: 20.854177157093673
Financial ratios for OCTVV — annual report dated 2023-12-31
Total revenue: 1540674000
Gross profit: 1090784000
Operating income: 318872000
Net income: 243905000
Capital expenditures: 9879000
Operating cash flow: 430020000
Depreciation & amortization: 124978000
Net tangible assets: -111134000
Owner earnings: 359004000
Return on net tangible assets (%): -323.0370543668005
Capex to operating income (%): 3.0981083318698412
Buffett classification: The Great
Shares outstanding: 257412788
Book value: 7576370000
Debt to equity: 0.008751948492483867
Current ratio: 1.055585942841515
Quick ratio: 1.0098928146924866
Effective tax rate (%): 24.096348047987306
COGS to revenue (%): 29.20085624862885
R&D to revenue (%): 9.409063825312817
SG&A to revenue (%): 31.36043056480475
Free cash flow (dilution-adjusted): 283720000
Inventory turnover: 17.26097298956415
Receivables turnover: 3.8153532982177216
Capitalized R&D asset: 226437680
ROCI (R&D-adjusted, %): 4.611339774843801
Rosenberg metric: 1.183628827999079
FCF margin (%): 18.415316932719055
Revenue growth (%): 12.59677076337178
Rule of 40 score: 31.012087696090834
Financial ratios for OCTVV — annual report dated 2024-12-31
Total revenue: 1604171000
Gross profit: 1170991000
Operating income: 390480000
Net income: 309090000
Capital expenditures: 7053000
Operating cash flow: 496866000
Depreciation & amortization: 137437000
Net tangible assets: -153055000
Owner earnings: 439474000
Return on net tangible assets (%): -287.13469014406587
Capex to operating income (%): 1.8062384757221879
Buffett classification: The Great
Shares outstanding: 257412788
Book value: 7537626000
Debt to equity: 0.008032104537953992
Current ratio: 1.0091350636749108
Quick ratio: 0.9841033659959203
Effective tax rate (%): 21.32211630245256
COGS to revenue (%): 27.003355627299086
R&D to revenue (%): 9.736929541800718
SG&A to revenue (%): 31.029547348755216
Free cash flow (dilution-adjusted): 340468000
Inventory turnover: 31.21118236184163
Receivables turnover: 4.198345441983166
Capitalized R&D asset: 293451530
ROCI (R&D-adjusted, %): 4.9676490906130235
Rosenberg metric: 0.5532929092251127
FCF margin (%): 21.223921888626588
Revenue growth (%): 4.121378046231714
Rule of 40 score: 25.345299934858303
Financial ratios for OCTVV — quarterly report dated 2025-03-31
Total revenue: 382804000
Gross profit: 283242000
Operating income: 73904000
Net income: 59486000
Capital expenditures: 1509000
Operating cash flow: 125509000
Depreciation & amortization: 40315000
Owner earnings: 98292000
Capex to operating income (%): 2.0418380601861874
Buffett classification: The Great
Shares outstanding: 257412788
Effective tax rate (%): 20.10476126519374
COGS to revenue (%): 26.008610150364152
R&D to revenue (%): 11.337917054158265
SG&A to revenue (%): 32.66162318053103
Free cash flow (dilution-adjusted): 88120000
Capitalized R&D asset: 43402000
ROCI (R&D-adjusted, %): 236.94453404605014
FCF margin (%): 23.01961317018631
Rule of 40 score: 23.01961317018631
Financial ratios for RR — annual report dated 2022-09-30
Total revenue: 6049000
Gross profit: 3951000
Operating income: -376000
Net income: -507000
Capital expenditures: 64000
Operating cash flow: -2646000
Net tangible assets: 2918000
Owner earnings: -571000
Return on net tangible assets (%): -19.568197395476354
Buffett classification: The Gruesome
Shares outstanding: 183661127
Book value: 2918000
Debt to equity: 0.13262508567511994
Current ratio: 4.730094466936572
Quick ratio: 2.8771929824561404
Interest coverage ratio: -20.88888888888889
COGS to revenue (%): 34.683418746900315
R&D to revenue (%): 29.294098198049262
SG&A to revenue (%): 42.23838651016697
Free cash flow (dilution-adjusted): -2646000
Retained earnings: 540000
Inventory turnover: 1.528040786598689
Receivables turnover: 3.429138321995465
Capitalized R&D asset: 1772000
ROCI (R&D-adjusted, %): 16.20715100288455
FCF margin (%): -43.74276739957018
Rule of 40 score: -43.74276739957018
Financial ratios for RR — annual report dated 2023-09-30
Total revenue: 8759000
Gross profit: 6015000
Operating income: 289000
Net income: -339000
Capital expenditures: 0
Operating cash flow: -2896000
Depreciation & amortization: 13000
Net tangible assets: 4809000
Owner earnings: -326000
Return on net tangible assets (%): -6.77895612393429
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 183661127
Book value: 4809000
Debt to equity: 0.2412143896860054
Current ratio: 2.415916955017301
Quick ratio: 2.131487889273356
Interest coverage ratio: 0.39373297002724794
COGS to revenue (%): 31.327777143509532
R&D to revenue (%): 22.593903413631693
SG&A to revenue (%): 42.77885603379381
Free cash flow (dilution-adjusted): -2896000
Retained earnings: 201000
Inventory turnover: 3.338199513381995
Receivables turnover: 1.5339754816112083
Capitalized R&D asset: 3166240
ROCI (R&D-adjusted, %): 12.518595424254503
Rosenberg metric: 1.164785553047404
FCF margin (%): -33.06313506108003
Revenue growth (%): 44.800793519590016
Rule of 40 score: 11.737658458509983
Financial ratios for SNM.V — annual report dated 2022-12-31
Total revenue: 129900735.29411764
Gross profit: 77897794.11764705
Operating income: 65884558.82352941
Net income: 84528676.47058822
Capital expenditures: 18999264.70588235
Operating cash flow: 77413970.58823529
Depreciation & amortization: 34252941.176470585
Net tangible assets: 120363235.29411764
Owner earnings: 99782352.94117646
Return on net tangible assets (%): 82.90102263980353
Capex to operating income (%): 28.837204111469482
Buffett classification: The Good
Shares outstanding: 2878504314
Book value: 120363235.29411763
Debt to equity: 1.7430082959668651
Current ratio: 4.067073170731707
Quick ratio: 4.067073170731707
Effective tax rate (%): 0.13464913042722867
Interest coverage ratio: 2.4355259581407993
COGS to revenue (%): 40.032830498400926
SG&A to revenue (%): 6.9323295502787765
Free cash flow (dilution-adjusted): 56758823.52941176
Retained earnings: -380292647.0588235
Receivables turnover: 2.001212066289831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.89069364251671
FCF margin (%): 43.69399711318031
Rule of 40 score: 43.69399711318031
Financial ratios for SNM.V — annual report dated 2023-12-31
Total revenue: 62792424.24242424
Gross profit: 23123484.848484848
Operating income: 3028787.8787878784
Net income: -20231818.18181818
Capital expenditures: 21209848.484848484
Operating cash flow: 30668181.818181816
Depreciation & amortization: 19763636.363636363
Net tangible assets: 105629545.45454545
Owner earnings: -21678030.3030303
Return on net tangible assets (%): -20.522695813699965
Capex to operating income (%): 700.2751375687844
Buffett classification: The Gruesome
Shares outstanding: 2878504314
Book value: 105629545.45454541
Debt to equity: 1.9649719215956287
Current ratio: 1.5721876656160219
Quick ratio: 1.5721876656160219
Interest coverage ratio: 0.10622243477336733
COGS to revenue (%): 63.17472190719783
SG&A to revenue (%): 14.901189585696015
Free cash flow (dilution-adjusted): 7890909.090909092
Retained earnings: -412084090.9090909
Receivables turnover: 2.1300336648420837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.055691837268193
FCF margin (%): 12.566657819173324
Revenue growth (%): -51.661224934369024
Rule of 40 score: -39.0945671151957
Financial ratios for SNM.V — annual report dated 2024-12-31
Total revenue: 76497902.0979021
Gross profit: 30262937.062937066
Operating income: 25390209.790209793
Net income: 57493706.2937063
Capital expenditures: 6130069.93006993
Operating cash flow: 68506993.00699301
Depreciation & amortization: 28486713.286713287
Net tangible assets: 156084615.3846154
Owner earnings: 79850349.65034966
Return on net tangible assets (%): 51.15837294635778
Capex to operating income (%): 24.143439462377433
Buffett classification: The Great
Shares outstanding: 2878504314
Book value: 156084615.3846154
Debt to equity: 0.964095142942908
Current ratio: 2.200805648200286
Quick ratio: 2.200805648200286
Effective tax rate (%): 0.2801799944206581
Interest coverage ratio: 1.3212037407663477
COGS to revenue (%): 60.43952025742284
SG&A to revenue (%): 10.52910633318707
Free cash flow (dilution-adjusted): 60143356.64335664
Retained earnings: -323068531.4685315
Receivables turnover: 4.56484727090636
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.095212614155251
FCF margin (%): 78.62092291940908
Revenue growth (%): 21.82664233915351
Rule of 40 score: 100.44756525856259
Financial ratios for SNM.V — quarterly report dated 2025-03-31
Total revenue: 25094405.594405595
Gross profit: 8724475.524475524
Operating income: 3665734.265734266
Net income: -773426.5734265734
Capital expenditures: 3576223.7762237764
Operating cash flow: 22400000
Depreciation & amortization: 9684615.384615386
Net tangible assets: 155597202.7972028
Owner earnings: 5334965.034965036
Capex to operating income (%): 97.5581838992751
Buffett classification: The Gruesome
Shares outstanding: 2878504314
Book value: 155597202.7972028
Debt to equity: 0.8483038507172905
Current ratio: 1.9932350424799536
Quick ratio: 1.9932350424799536
Interest coverage ratio: 0.7742983751846382
COGS to revenue (%): 65.23338442246065
SG&A to revenue (%): 23.817751149505366
Free cash flow (dilution-adjusted): 19972727.272727273
Retained earnings: -323841958.04195803
Receivables turnover: 1.7756061355764474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2493684039926403
FCF margin (%): 79.59035808833774
Rule of 40 score: 79.59035808833774
Financial ratios for SNM.V — quarterly report dated 2025-06-30
Total revenue: 25828467.15328467
Gross profit: 9324817.518248174
Operating income: 8192700.729927007
Net income: 2567883.211678832
Capital expenditures: 590510.9489051094
Operating cash flow: 19305109.489051092
Depreciation & amortization: 9973722.627737226
Net tangible assets: 165330656.93430656
Owner earnings: 11951094.890510947
Return on net tangible assets (%): 7.228601828673349
Capex to operating income (%): 7.207769066286527
Buffett classification: The Great
Shares outstanding: 2878504314
Book value: 165330656.9343066
Debt to equity: 0.6962821684480999
Current ratio: 3.791793056959892
Quick ratio: 3.791793056959892
Effective tax rate (%): 2.0873921514055107
Interest coverage ratio: 1.3411399211375314
COGS to revenue (%): 63.897131552917905
SG&A to revenue (%): 7.223399745654939
Free cash flow (dilution-adjusted): 18572262.773722626
Retained earnings: -335456934.30656934
Receivables turnover: 1.5851364063969895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6727309528628744
FCF margin (%): 71.90617493288116
Revenue growth (%): 2.925200025629303
Rule of 40 score: 74.83137495851047
Financial ratios for SNM.V — quarterly report dated 2025-09-30
Total revenue: 20817266.18705036
Gross profit: 6674820.143884893
Operating income: 4243884.892086331
Net income: 1346043.165467626
Capital expenditures: 1257553.9568345326
Operating cash flow: 4261151.079136691
Depreciation & amortization: 7267625.899280576
Net tangible assets: 164623741.00719425
Owner earnings: 7356115.107913669
Return on net tangible assets (%): 4.468441224156241
Capex to operating income (%): 29.632141040854385
Buffett classification: The Good
Shares outstanding: 2878504314
Book value: 164647482.01438847
Debt to equity: 0.6372454775845496
Current ratio: 4.438327526132404
Quick ratio: 4.438327526132404
Effective tax rate (%): 0.9528851244044468
Interest coverage ratio: 1.2387652246955059
COGS to revenue (%): 67.9361349184407
SG&A to revenue (%): 10.260575062206248
Free cash flow (dilution-adjusted): 1916546.7625899285
Retained earnings: -329283453.23741007
Receivables turnover: 1.045262435429686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4299912731503928
FCF margin (%): 9.206524744263204
Revenue growth (%): -19.40185198174651
Rule of 40 score: -10.195327237483307
Financial ratios for SNM.V — quarterly report dated 2025-12-31
Total revenue: 39900000
Gross profit: 22275182.481751822
Operating income: 19410948.905109487
Net income: 16454744.525547445
Capital expenditures: 6188321.167883211
Operating cash flow: 3409489.05109489
Depreciation & amortization: 9164233.576642334
Net tangible assets: 182261313.86861312
Owner earnings: 19430656.93430657
Return on net tangible assets (%): 10.660878341035971
Capex to operating income (%): 31.88057007483172
Buffett classification: The Good
Shares outstanding: 2878504314
Book value: 182318978.10218975
Debt to equity: 0.5844132966606214
Current ratio: 4.744374886590455
Quick ratio: 4.744374886590455
Effective tax rate (%): 0.031042128603104215
Interest coverage ratio: 3.818638713383113
COGS to revenue (%): 44.17247498307813
SG&A to revenue (%): 6.360792492179352
Free cash flow (dilution-adjusted): -1789781.0218978103
Retained earnings: -317534306.56934303
Receivables turnover: 0.8821592834664731
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.174094943571099
FCF margin (%): -4.485666721548396
Revenue growth (%): 91.66781863422725
Rule of 40 score: 87.18215191267885
Financial ratios for SNM.V — annual report dated 2025-12-31
Total revenue: 113043065.69343065
Gross profit: 47478832.11678832
Operating income: 35735766.42335766
Net income: 19581751.824817516
Capital expenditures: 6148175.182481752
Operating cash flow: 50418978.10218978
Depreciation & amortization: 36620437.95620438
Net tangible assets: 182261313.86861312
Owner earnings: 50054014.59854014
Return on net tangible assets (%): 27.462775032238945
Capex to operating income (%): 17.204542669226687
Buffett classification: The Great
Shares outstanding: 2878504314
Book value: 182318978.10218975
Debt to equity: 0.5844132966606214
Current ratio: 4.744374886590455
Quick ratio: 4.744374886590455
Effective tax rate (%): 0.3972673943714265
Interest coverage ratio: 2.0630399056086977
COGS to revenue (%): 57.999341378842765
SG&A to revenue (%): 11.331512439545682
Free cash flow (dilution-adjusted): 40850364.963503644
Retained earnings: -317534306.56934303
Receivables turnover: 2.4992979908012587
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.36657542388425
FCF margin (%): 36.136993200705106
Revenue growth (%): 47.772765779587004
Rule of 40 score: 83.90975898029211
Financial ratios for 389A.T — annual report dated 2023-12-31
Total revenue: 7520321.0068585165
Gross profit: 1532800.6787810223
Operating income: 129265.36095594993
Net income: 48525.77246694478
Capital expenditures: 920992.7172452803
Operating cash flow: 75281.05776709325
Depreciation & amortization: 200014.1412713003
Net tangible assets: 6541851.0924132075
Owner earnings: -672452.8035070351
Return on net tangible assets (%): -10.279243504745928
Capex to operating income (%): 712.482222951537
Buffett classification: The Gruesome
Shares outstanding: 547625
Book value: 7037707.699922223
Debt to equity: 0.40891632331769046
Current ratio: 2.1361109999510894
Quick ratio: 2.0804820787813303
Effective tax rate (%): 33.74203514191929
Interest coverage ratio: 7.859845227858984
COGS to revenue (%): 79.6177882829901
Free cash flow (dilution-adjusted): -1181899.172735629
Retained earnings: 5991875.839637984
Inventory turnover: 33.84277835504756
Receivables turnover: 11.978275559159403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3582133573248203
FCF margin (%): -15.716073444973153
Rule of 40 score: -15.716073444973153
Financial ratios for 389A.T — annual report dated 2024-12-31
Total revenue: 7289368.749601885
Gross profit: 2108357.2202051086
Operating income: 332613.54226383846
Net income: 389910.18536212493
Capital expenditures: 193891.3306580037
Operating cash flow: 702305.8793553729
Depreciation & amortization: 291101.3440346519
Net tangible assets: 6348894.834065864
Owner earnings: 487120.1987387731
Return on net tangible assets (%): 7.672519571832613
Capex to operating income (%): 58.29327613612425
Buffett classification: The Good
Shares outstanding: 547625
Book value: 6730071.979106949
Debt to equity: 0.3446184482761885
Current ratio: 2.2204087113391027
Quick ratio: 2.1589599481569848
Effective tax rate (%): 21.811771919068057
Interest coverage ratio: 27.96839850026781
COGS to revenue (%): 71.07618420109792
Free cash flow (dilution-adjusted): 408229.82355564047
Retained earnings: 5787897.318300528
Inventory turnover: 25.75899417278946
Receivables turnover: 7.3345468296340925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6818039196330683
FCF margin (%): 5.600345346473744
Revenue growth (%): -3.071042539886313
Rule of 40 score: 2.529302806587431
Financial ratios for 389A.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 7339738.44450595
Buffett classification: The Gruesome
Shares outstanding: 547625
Book value: 7709202.878494325
Debt to equity: 0.23293338144244768
Current ratio: 2.2971677952876317
Quick ratio: 2.2525594927675456
Retained earnings: 6737628.009964018
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9880.HK — annual report dated 2021-12-31
Total revenue: 128293563.57927786
Gross profit: 40181004.70957614
Operating income: -136359811.61695448
Net income: -144037519.6232339
Capital expenditures: 36127472.527472526
Operating cash flow: -106859654.6310832
Depreciation & amortization: 15652276.295133438
Net tangible assets: 40289952.90423862
Owner earnings: -164512715.855573
Return on net tangible assets (%): -408.3219363561623
Buffett classification: The Gruesome
Shares outstanding: 432735396
Book value: 119308948.19466245
Debt to equity: 1.1122845060118582
Current ratio: 0.950237315112886
Quick ratio: 0.7025399647731645
Interest coverage ratio: -26.95711004903482
COGS to revenue (%): 68.68042044467286
R&D to revenue (%): 63.271294494817866
SG&A to revenue (%): 22.406299328218495
Free cash flow (dilution-adjusted): -168848194.66248038
Retained earnings: -538692778.6499215
Inventory turnover: 1.353854651849958
Receivables turnover: 2.2199796264855687
Capitalized R&D asset: 81172998.43014129
ROCI (R&D-adjusted, %): -34.68156765808748
FCF margin (%): -131.61080723908816
Rule of 40 score: -131.61080723908816
Financial ratios for 9880.HK — annual report dated 2022-12-31
Total revenue: 144866666.66666666
Gross profit: 57064367.816091955
Operating income: -116369109.1954023
Net income: -140058764.3678161
Capital expenditures: 44039798.85057471
Operating cash flow: -77398994.25287357
Depreciation & amortization: 11591666.666666666
Net tangible assets: 61262787.35632184
Owner earnings: -172506896.55172414
Return on net tangible assets (%): -281.585125319837
Buffett classification: The Gruesome
Shares outstanding: 432735396
Book value: 151425862.06896552
Debt to equity: 0.6535537666852639
Current ratio: 1.0151440642875202
Quick ratio: 0.8163577001015029
Interest coverage ratio: -33.146265602619195
COGS to revenue (%): 60.60904200453846
R&D to revenue (%): 42.47663328942984
SG&A to revenue (%): 15.000119015503751
Free cash flow (dilution-adjusted): -152628879.31034482
Retained earnings: -638672270.1149426
Inventory turnover: 2.252976113669293
Receivables turnover: 1.5520114522323385
Capitalized R&D asset: 115920391.70681536
ROCI (R&D-adjusted, %): -31.95651820692672
Rosenberg metric: 0.20799235500763097
FCF margin (%): -105.35817715854452
Revenue growth (%): 12.918109548923393
Rule of 40 score: -92.44006760962112
Financial ratios for AMAN — quarterly report dated 2026-01-31
Capital expenditures: 0
Net tangible assets: 5413
Buffett classification: The Gruesome
Shares outstanding: 7500000
Book value: 5413
Debt to equity: 2.4016257158692036
Current ratio: 0.002888816668472177
Quick ratio: 0.002888816668472177
Retained earnings: -19587
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATPC — annual report dated 2022-12-31
Total revenue: 420037.1040723982
Gross profit: 269348.86877828056
Operating income: -346892.7601809955
Net income: -376940.95022624434
Capital expenditures: 2134.1628959276018
Operating cash flow: -183638.68778280544
Depreciation & amortization: 49307.692307692305
Net tangible assets: 343415.61085972853
Owner earnings: -329767.42081447964
Return on net tangible assets (%): -96.0257514179157
Buffett classification: The Gruesome
Shares outstanding: 1000626
Book value: 353496.3800904978
Debt to equity: 0.05293467839693201
Current ratio: 1.6501604578233864
Quick ratio: 1.612515303486958
COGS to revenue (%): 35.87498195591426
SG&A to revenue (%): 146.71123645616308
Free cash flow (dilution-adjusted): -190905.42986425338
Retained earnings: -1118910.8597285068
Inventory turnover: 14.39250599649934
Receivables turnover: 103.7186592178771
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -98.13191300351882
FCF margin (%): -45.449658616670355
Rule of 40 score: -45.449658616670355
Financial ratios for CBNA — annual report dated 2022-12-31
Total revenue: 29211000
Net income: 8281000
Capital expenditures: 88000
Operating cash flow: 17342000
Depreciation & amortization: 501000
Net tangible assets: 68783000
Owner earnings: 8694000
Return on net tangible assets (%): 12.639751101289562
Buffett classification: The Gruesome
Shares outstanding: 3366667
Book value: 68783000
Debt to equity: 0.07269238038468807
Effective tax rate (%): 18.518154088359736
COGS to revenue (%): 0
SG&A to revenue (%): 43.50073602410051
Free cash flow (dilution-adjusted): 17254000
Retained earnings: 48121000
Receivables turnover: 6.772779967539996
Capitalized R&D asset: 0
FCF margin (%): 59.0667899079114
Rule of 40 score: 59.0667899079114
Financial ratios for CBNA — annual report dated 2023-12-31
Total revenue: 30220000
Net income: 8831000
Capital expenditures: 269000
Operating cash flow: 12812000
Depreciation & amortization: 491000
Net tangible assets: 83437000
Owner earnings: 9053000
Return on net tangible assets (%): 10.85010247252418
Buffett classification: The Gruesome
Shares outstanding: 3366667
Book value: 83437000
Debt to equity: 0.05992545273679543
Effective tax rate (%): 19.026224096827434
COGS to revenue (%): 0
SG&A to revenue (%): 45.58239576439444
Free cash flow (dilution-adjusted): 12543000
Retained earnings: 56692000
Receivables turnover: 6.940744143316491
Capitalized R&D asset: 0
FCF margin (%): 41.505625413633354
Revenue growth (%): 3.45417822053336
Rule of 40 score: 44.95980363416671
Financial ratios for CPH2.L — annual report dated 2021-12-31
Total revenue: 37837.83783783784
Gross profit: 4054.054054054054
Operating income: -4495945.945945946
Net income: -4482432.432432433
Capital expenditures: 431081.08108108107
Operating cash flow: -2840540.5405405406
Depreciation & amortization: 222972.972972973
Net tangible assets: -2064864.8648648649
Owner earnings: -4690540.540540541
Buffett classification: The Gruesome
Shares outstanding: 671346416
Book value: -475675.6756756762
Debt to equity: -3.889204545454541
Current ratio: 1.0377473363774734
Quick ratio: 0.40395738203957376
Interest coverage ratio: -89.9189189189189
COGS to revenue (%): 89.28571428571429
SG&A to revenue (%): 7660.714285714284
Free cash flow (dilution-adjusted): -5764864.864864865
Retained earnings: -7986486.486486486
Inventory turnover: 0.012007684918347744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -121.1139424827084
FCF margin (%): -15235.714285714286
Rule of 40 score: -15235.714285714286
Financial ratios for DIFFNKG.NS — annual report dated 2023-03-31
Total revenue: 30757369.06211937
Gross profit: 8774665.042630939
Operating income: 3266017.0523751527
Net income: 2699634.5919610234
Capital expenditures: 1106090.1339829478
Operating cash flow: -576979.293544458
Depreciation & amortization: 467844.0925700366
Net tangible assets: 17264555.420219246
Owner earnings: 2061388.5505481123
Return on net tangible assets (%): 11.940003668637383
Capex to operating income (%): 33.86663683150593
Buffett classification: The Good
Shares outstanding: 37126259
Book value: 17316321.5590743
Debt to equity: 0.33827118810975826
Current ratio: 1.6978575352499545
Quick ratio: 1.0666056277848994
Effective tax rate (%): 22.732030704815074
Interest coverage ratio: 14.462783171521037
COGS to revenue (%): 71.47134065690366
SG&A to revenue (%): 3.7141906715560875
Free cash flow (dilution-adjusted): -1698294.7624847747
Retained earnings: 14761144.945188794
Inventory turnover: 3.4902628169177516
Receivables turnover: 3.600456262921509
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.065202891618213
FCF margin (%): -5.521586579966577
Rule of 40 score: -5.521586579966577
Financial ratios for DIFFNKG.NS — annual report dated 2024-03-31
Total revenue: 33073989.687012833
Gross profit: 10811008.514210338
Operating income: 4387336.611104449
Net income: 3693968.10169085
Capital expenditures: 3748171.243554383
Operating cash flow: 4362513.490826238
Depreciation & amortization: 545509.0538433865
Net tangible assets: 22818083.703081906
Owner earnings: 491305.91197985364
Return on net tangible assets (%): 2.153142737019129
Capex to operating income (%): 85.43158585251189
Buffett classification: The Gruesome
Shares outstanding: 37126259
Book value: 22906703.44165967
Debt to equity: 0.18027002549484605
Current ratio: 1.891302403434573
Quick ratio: 1.2113898010554154
Effective tax rate (%): 25.021906338233862
Interest coverage ratio: 25.892427459306443
COGS to revenue (%): 67.3126568142594
SG&A to revenue (%): 3.5623123667532006
Free cash flow (dilution-adjusted): 507374.9850101931
Retained earnings: 17972418.75524643
Inventory turnover: 3.488893482673081
Receivables turnover: 4.1382807928338865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.54700118117621
FCF margin (%): 1.5340604197183507
Revenue growth (%): 7.5319206275890584
Rule of 40 score: 9.065981047307409
Financial ratios for ECO — annual report dated 2022-12-31
Total revenue: 288268532.9787234
Gross profit: 131045548.93617022
Operating income: 117151779.78723405
Net income: 89957441.4893617
Capital expenditures: 190001407.44680852
Operating cash flow: 87787155.31914894
Depreciation & amortization: 40386089.36170213
Net tangible assets: 449194958.5106383
Owner earnings: -59657876.595744684
Return on net tangible assets (%): -13.281065485139857
Capex to operating income (%): 162.18397005310612
Buffett classification: The Gruesome
Shares outstanding: 39044655
Book value: 449194958.51063836
Debt to equity: 1.7502604523509493
Current ratio: 1.6630517470671822
Quick ratio: 1.4798504400264332
Interest coverage ratio: 3.139429060275546
COGS to revenue (%): 54.54046004187268
SG&A to revenue (%): 1.9546358188237907
Free cash flow (dilution-adjusted): -102214252.12765957
Retained earnings: 155742613.82978725
Inventory turnover: 8.688124139099477
Receivables turnover: 5.399093405932163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.098331343428658
FCF margin (%): -35.45799850974502
Rule of 40 score: -35.45799850974502
Financial ratios for ETSS — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 8478
Buffett classification: The Gruesome
Shares outstanding: 15000000
Book value: 8478
Debt to equity: 2.6916725642840293
Current ratio: 0.11751279646557666
Quick ratio: 0.11751279646557666
Retained earnings: -16522
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ETSS — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -45622
Net income: -45622
Capital expenditures: 0
Operating cash flow: 0
Net tangible assets: -20622
Owner earnings: -45622
Buffett classification: The Gruesome
Shares outstanding: 15000000
Book value: -20622
Debt to equity: -5.126951799049559
Current ratio: 0
Quick ratio: 0
Free cash flow (dilution-adjusted): 0
Retained earnings: -45622
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ETSS — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: 0
Net income: 0
Capital expenditures: 0
Operating cash flow: 0
Owner earnings: 0
Buffett classification: The Gruesome
Shares outstanding: 15000000
Free cash flow (dilution-adjusted): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ETSS — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: -20622
Buffett classification: The Gruesome
Shares outstanding: 15000000
Book value: -20622
Debt to equity: -6.031325768596644
Quick ratio: 0
Retained earnings: -45622
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HITECHCORP.NS — annual report dated 2023-03-31
Total revenue: 67787551.76613887
Gross profit: 24104762.484774668
Operating income: 5769829.476248478
Net income: 3450572.472594397
Capital expenditures: 2190255.785627284
Operating cash flow: 8444482.33861145
Depreciation & amortization: 3483885.5054811207
Net tangible assets: 29608940.31668697
Owner earnings: 4744202.192448233
Return on net tangible assets (%): 16.022870598224355
Capex to operating income (%): 37.96049423372873
Buffett classification: The Good
Shares outstanding: 17175700
Book value: 29623641.900121804
Debt to equity: 0.25923183288851903
Current ratio: 1.1865350830041246
Quick ratio: 0.6764887193591012
Effective tax rate (%): 24.175015323342606
Interest coverage ratio: 3.440633647833003
COGS to revenue (%): 64.44072420857742
SG&A to revenue (%): 3.1676129370293875
Free cash flow (dilution-adjusted): 6170353.227771011
Retained earnings: 20933118.14859927
Inventory turnover: 9.568619865316274
Receivables turnover: 15.218037341266806
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.744104439706387
FCF margin (%): 9.102487207471647
Rule of 40 score: 9.102487207471647